Dixon Jonathan V. 4

What Happened
Jonathan V. Dixon, General Counsel of Bionano Genomics, had 24 shares of common stock withheld by the company on June 3, 2026 to satisfy tax withholding obligations related to RSUs that vested that day. The shares were valued at $1.30 each for a total of $31 and were not issued to Dixon (they were surrendered/withheld rather than sold on the open market).

Key Details

• Transaction date: 2026-06-03; Filing date (Form 4): 2026-06-03 (timely filed).
• Transaction type/code: F — tax withholding in connection with RSU settlement.
• Shares withheld/disposed: 24 shares at $1.30 each; total value reported $31.
• Footnote: RSUs were granted on June 3, 2024 and vested on June 3, 2026; the issuer withheld 24 shares to cover the reporting person’s tax withholding obligations.
• Shares owned after transaction: Not specified in the provided filing.

Context
This was a routine tax-withholding action tied to RSU vesting (a common, non-transactional disposal) rather than an open-market sale or purchase. Such withholdings are standard and generally do not signal a buy/sell preference by the insider.